Unlock the White Home Watch publication without spending a dime
GTCR has kicked off a sale of healthcare know-how firm Cedar Gate Applied sciences, which is anticipated to fetch greater than $1bn, in what could be the newest in a collection of exits by the non-public fairness group, in response to individuals aware of the matter.
The Chicago-based agency is working with advisers on the sale, which is probably going to attract curiosity from strategic consumers in addition to rival sponsors, 4 individuals stated. Closing bids are anticipated within the coming month, two of them added.
Cedar Gate’s know-how permits customers to sift tens of hundreds of items of information, offering them with a platform that provides affected person analytics, inhabitants well being and funds info. Its prospects serve greater than 60mn insured Individuals.
GTCR expects to fetch greater than $1bn together with debt for the Greenwich, Connecticut-based enterprise. If a sale is clinched, it will likely be the newest in a collection of profitable non-public fairness exits throughout a dry patch for mergers and acquisitions as deal exercise has dropped due to market turmoil unleashed by President Donald Trump’s tariff coverage.
The individuals warned {that a} sale of the corporate isn’t assured and GTCR may choose to carry on to the corporate, or promote a stake within the enterprise. GTCR declined to remark. Cedar Gate didn’t instantly reply to a request for remark.
The public sale course of comes amid what is ready to be a banner 12 months for GTCR, which was based in 1980.
This month, GTCR agreed to promote its 55 per cent stake in Worldpay to rival International Funds in a cash-and-stock deal which valued the funds supplier at $24.2bn, lower than two years after shopping for the corporate for $18.5bn.*
The exit netted GTCR a two-fold return on its funding and has put it on observe to reap a multi-billion-dollar windfall, the FT beforehand reported.
GTCR’s speedy exit from Worldpay strikes a distinction with the non-public fairness deal market at massive the place rivals have largely held on to property for longer to keep away from promoting portfolio firms at a cut-price valuation.
That downside has been compounded by struggles with debt financing and the truth that slower-than-expected rate of interest cuts from the US Federal Reserve have hobbled leveraged buyouts.
GTCR additionally struck a deal to promote a stake in hedge fund knowledge supplier Ultimus Fund Options to Stone Level Capital in a deal valuing the enterprise at approaching $2bn this week.
GTCR controls $45bn of property beneath administration, deployed throughout a number of sectors together with healthcare, monetary providers and know-how.
*This story has been amended to make clear that the stake was bought to International Funds